Il mercato dei controlli di qualità molecolari comprende uno spettro di prodotti progettati per sostenere la precisione e l'affidabilità dei test diagnostici molecolari attraverso la fornitura di materiali standardizzati per la garanzia della qualità e i test di competenza. Questi controlli sono impiegati per supervisionare l'efficacia dei test molecolari, comprendendo tecniche come la reazione a catena della polimerasi (PCR), il sequenziamento di nuova generazione (NGS) e altre metodologie basate sugli acidi nucleici , all'interno di diversi contesti di laboratorio , tra cui diagnostica clinica, ricerca e sviluppo farmaceutico. I controlli di qualità molecolari servono a rilevare e correggere discrepanze, convalidare le prestazioni del test, aderire ai mandati normativi e, in ultima analisi, garantire la diffusione di risultati di test precisi e replicabili, aumentando così gli standard di assistenza ai pazienti e promuovendo la fiducia nei protocolli di test diagnostici.
La genomica è emersa come un aspetto fondamentale nell'avvento della medicina personalizzata , offrendo strategie terapeutiche e preventive su misura, adattate alle condizioni individuali per risultati ottimizzati. Questo paradigma medico è molto promettente nell'affrontare disturbi che finora hanno mostrato una risposta limitata ai trattamenti o ai rimedi convenzionali. Secondo il rapporto sulla medicina personalizzata pubblicato dalla Personalized Medicine Coalition, nel 2022, il Center for Drug Evaluation and Research (CDER) della FDA ha sanzionato 37 nuove entità molecolari (NME), con due NME designate come prodotti terapeutici e le restanti classificate come agenti diagnostici. Delle 35 nuove entità molecolari terapeutiche approvate dalla FDA statunitense, 12 erano interventi di medicina personalizzata, insieme a cinque nuove terapie basate sulle cellule.
| ATTRIBUTO | DETTAGLI |
| Periodo di studio | 2020-2029 |
| Anno base | 2021 |
| Anno stimato | 2022 |
| Anno previsto | 2022-2029 |
| Periodo storico | 2018-2020 |
| Unità | Valore (milioni di USD) |
| Segmentazione | Per prodotto, per applicazione, per tipo di analita, per settore di utilizzo finale, per regione |
| Per Prodotto |
|
| Per applicazione |
|
| Per tipo di analita |
|
| Per uso finale Industria |
|
| Per regione |
|
Negli ultimi sei anni, il costo del sequenziamento del genoma ha assistito a un rapido declino, stimato in una riduzione di circa un milione di volte. Il Progetto Genoma Umano, uno sforzo collaborativo che ha coinvolto migliaia di ricercatori nell'arco di 13 anni, ha sostenuto una spesa totale di 2,7 miliardi di USD, come documentato da WIRED nel settembre 2022. Un post del blog pubblicato su Sequencing in 2022 evidenzia il crescente interesse per il sequenziamento del DNA, spingendo numerose aziende bioinformatiche a concentrarsi su nuove tecnologie pionieristiche, piattaforme di sequenziamento e materiali di consumo con l'obiettivo di democratizzare i test genetici offrendoli a prezzi più accessibili.
The Molecular quality controls market size had crossed USD 154.43 Billion in 2020 and is expected to grow till USD 278.21 billion by 2029.
The Largest Regional market for Molecular quality controls market is APAC having a market share of 39%.
The global Molecular quality controls market registered a CAGR of 6.90% from 2022 to 2029.
Key players profiled in the report include F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Randox Laboratories Ltd., LGC Limited, Abbott Laboratories, Fortress Diagnostics, SERO AS, Anchor Molecular, Ortho-Clinical Diagnostics, Inc. , Quidel Corporation , Sun Diagnostics, LLC , Seegene Inc. , ZeptoMetrix, LLC, Qnostics ,Bio-Techne Corporation, Microbiologics, Inc., Microbix Biosystems Inc., SpeeDx Pty. Ltd., Maine Molecular Quality Controls, Inc., and Grifols, S.A.
The Molecular Quality Controls market is segmented by Product and service, Application, technology and end user.
On the basis of Product, the global Molecular Quality Control market is segmented into Independent, Instrument Specific (PCR, DNA Sequencing). The independent control segment held the greatest proportion of the global molecular quality control market. The expansion of the molecular quality control products market is being driven by an increase in the number of certified laboratories and regulatory mandates for the adoption of quality controls to ensure the accuracy of diagnostic test findings.
On the basis of Application, the global Molecular Quality Control market is segmented into Infectious Diseases Diagnostic, Oncology testing, genetic testing, others. The infectious disease diagnostics sector held the greatest proportion of the molecular quality controls market. The development of advanced assays for infectious diseases, a significant increase in the prevalence of infectious diseases, and rising awareness about the effective use of molecular diagnostic technologies to control the occurrence and spread of infectious diseases are all factors contributing to this segment's size.
On the basis of Analyte type, the global Molecular Quality Control market is segmented into Single-analyte Controls, Multi-analyte Controls. Due to the widespread use of single plex assays in hospitals and the benefits associated with single-analyte controls, such as straightforward analysis and interpretation and little risk of cross-reactivity, single-analyte controls dominated the molecular quality controls market in 2020.
On the basis of End use industry, the global Molecular Quality Control market is segmented into Diagnostic Laboratories, Hospitals, IVD Manufacturers & CROs, Academic and Research Institutes, Others.
[caption id="attachment_9572" align="alignleft" width="680"]
The Key Players in Molecular Quality Controls market are F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Randox Laboratories Ltd. , LGC Limited , Abbott Laboratories , Fortress Diagnostics , SERO AS , Anchor Molecular, Ortho-Clinical Diagnostics, Inc. , Quidel Corporation , Sun Diagnostics, LLC , Seegene Inc. , ZeptoMetrix, LLC, Qnostics , Bio-Techne Corporation , Microbiologics, Inc., Microbix Biosystems Inc., SpeeDx Pty. Ltd., Maine Molecular Quality Controls, Inc., and Grifols, S.A..
In February 2020, The EDX RP Positive Run Control from Bio-Rad Laboratories (US) is the first multi-analyte control to target 22 analytes in a single vial, saving laboratories time and space on their equipment. AcroMetrix Coronavirus 2019 (COVID-19) RNA Control was also introduced by Thermo Fisher Scientific (US).
Geographically, Molecular Quality Controls market is segmented into North America, Europe, Asia Pacific, and Rest of the world.
North America was the largest regional market for molecular quality controls due to the sophisticated healthcare systems in the United States and Canada, the existence of several major molecular quality control product manufacturers in the region, and easy access to technologically advanced goods.
The market in Asia Pacific, on the other hand, is expected to develop at the fastest rate over the projected period. The presence of rising economies like as China and India, as well as the strong need for high-quality and accurate diagnostic tests from the region's vast patient population, are driving the Asia Pacific molecular quality controls market forward.
[caption id="attachment_9615" align="alignnone" width="680"]
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.